Home Cart Sign in  
Chemical Structure| 143491-57-0 Chemical Structure| 143491-57-0

Structure of Emtricitabine
CAS No.: 143491-57-0

Chemical Structure| 143491-57-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Emtricitabine is a reverse transcriptase inhibitor used to treat HIV infection.

Synonyms: BW1592; BW 524W91; Emtriva.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Emtricitabine

CAS No. :143491-57-0
Formula : C8H10FN3O3S
M.W : 247.25
SMILES Code : NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1
Synonyms :
BW1592; BW 524W91; Emtriva.
MDL No. :MFCD00870151
InChI Key :XQSPYNMVSIKCOC-NTSWFWBYSA-N
Pubchem ID :60877

Safety of Emtricitabine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02327663 Hepatitis B, Chronic PHASE4 UNKNOWN 2025-12-17 -
NCT00743340 HIV-1 Infection PHASE2 COMPLETED 2017-02-13 Themba Lethu Clinic, Helen Jos... More >>eph Hospital, Westdene, Johannesburg, South Africa|Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa Less <<
NCT02327715 Hepatitis B, Chronic|Pregnancy PHASE4 UNKNOWN 2025-07-16 -
NCT02327702 Hepatitis B, Chronic|Pregnancy PHASE4 UNKNOWN 2025-07-17 -
NCT00476463 Hepatitis B Virus|HIV Infectio... More >>ns Less << PHASE2 COMPLETED 2025-12-08 HIV-NAT Thai Red Cross AIDS Re... More >>search Center, Bangkok, 10330, Thailand Less <<
NCT00002335 HIV Infections PHASE1 COMPLETED - ViRx Inc, San Francisco, Calif... More >>ornia, 94103, United States Less <<
NCT02327676 Hepatitis B, Chronic PHASE4 UNKNOWN 2025-07-16 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.04mL

0.81mL

0.40mL

20.22mL

4.04mL

2.02mL

40.44mL

8.09mL

4.04mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories